论文部分内容阅读
目的:观察卡孕栓联合催产素、卡孕栓、催产素3种不同方法预防产后出血的效果。方法:设卡孕栓联合催产素组、卡孕栓组和催产素组。卡孕栓联合催产素组是在胎儿娩出后卡孕栓联合催产素使用,卡孕栓组是在第三产程初使用卡孕栓,而催产素组在第三产程时肌注催产素,选取240例足月妊娠,无合并症或有并发症的自然临产孕妇,随机分为3组,每组80例。结果:卡孕栓联合催产素组预防产后出血优于卡孕栓组,而卡孕栓组优于催产素组,P<0.01。结论:卡孕栓联合催产素对预防产后出血效果显著,不良反应小,使用方便,值得临床推广应用。
Objective: To observe the effects of carbamazepine combined with oxytocin, carbamazepine and oxytocin on preventing postpartum hemorrhage. Methods: Suppository suppository combined oxytocin group, card pregnant suppository group and oxytocin group. The combination of carbamazepine and oxytocin was used in combination with oxytocin after the fetus was delivered. The carbamazepine group was given carbamazepine at the beginning of the third stage of labor, and the oxytocin was injected intramuscularly in the third stage of labor. 240 pregnant women with term pregnancy, no complications or complications of natural pregnancy were randomly divided into 3 groups, 80 cases in each group. Results: The combination of carbamazepine and oxytocin was superior to carbamazepine in preventing postpartum hemorrhage, while carbamazepine group was better than oxytocin group (P <0.01). CONCLUSION: The combination of carbamazepine and oxytocin has a significant effect in preventing postpartum hemorrhage with small adverse reactions and is easy to use. It is worthy of clinical application.